
Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland
Policy Landscape – National and Local Catalysts
Reforms enacted in 2024-2025 have significantly accelerated sector development. Nationally, China relaxed restrictions on foreign investment in gene and cell therapy and allowed the establishment of wholly foreign-owned hospitals in key cities. Regulatory incentives – such as data protection and marketing exclusivity – have improved market access for innovative drugs. Locally, cities like Beijing, Shanghai, Shenzhen, Guangzhou, and Suzhou are rolling out targeted subsidies, fast-track approvals, and ecosystem-building programmes that directly benefit biotech development.
Recent national policy initiatives on the Chinese mainland
Industry Innovation and Company Growth
Chinese life sciences companies are moving beyond generic drug manufacturing toward innovative therapies. Firms like Akeso, BeiGene, Gracell, and Legend Biotech are now global players, leading in CAR-T, bispecific antibodies, and AI-assisted R&D. These companies are not only commercialising cutting-edge treatments but also attracting international investment and licensing agreements, reinforcing the Chinese mainland's global relevance in life sciences.
Real Estate Development and Regional Hubs
Innovation hubs such as Suzhou BioBAY, Zhangjiang Hi-Tech Park (Shanghai), and the Bioisland Innovation Centre (Guangdong) are central to regional clustering. These hubs offer end-to-end support, including shared labs, venture capital access, GMP-compliant facilities, and proximity to academic and clinical networks. The rise of second-tier innovation cities like Chengdu and Ningbo further expands growth corridors.
The 'R&D + Manufacturing + Service' ecosystem
Source: Cushman & Wakefield Research
Landlord Perspectives – Evolving Real Estate Models
Real estate developers and landlords are adapting to sector-specific requirements through asset-light models, flexible leasing, and high-specification lab and production space. Tier-1 cities face saturation, but central and western regions exhibit healthy demand. Developers are incorporating advanced sustainability and compliance features to meet growing regulatory and ESG expectations, particularly in GMP and cleanroom environments.
Digitalisation, environmental policies, and differentiated tenant strategies are shaping performance. Operators now focus on integrated ecosystems with platforms that link tenants to R&D services, policy benefits, and technology partners.
Occupier Perspectives – Growth, Innovation, and Challenges
Life sciences occupiers are navigating regulatory reform, rising compliance demands, and intensified market competition. Many are localising production and R&D, leveraging regional subsidies, and investing in AI-powered innovation platforms. Occupiers seek flexibility, proximity to talent and infrastructure, and co-located R&D and manufacturing to support accelerated innovation and operational agility.
In real estate, demand is strongest for GMP-certified labs, modular production facilities, and shared innovation platforms. Occupiers emphasise location advantages, sustainability certifications (e.g., LEED, WELL), and integration into clusters that enable faster time-to-market.
Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, 'Life sciences business parks on the Chinese mainland demonstrated clear regional differentiation, highlighting opportunities for strategic positioning. While Tier-1 cities saw more moderate performance due to broader macroeconomic factors and abundant supply, core cities in central and western regions recorded healthy occupancy rates, underpinned by strong industrial clustering and increasingly sophisticated ecosystems – contributing to steady growth in asset value.'
Johnathan Wei, President, Project & Occupier Services, China, said, 'Several interviewed life sciences companies on the Chinese mainland achieved revenue growth supported by innovative products and favourable policy tailwinds. While overall growth remained modest for many, a select group reported strong performance, highlighting opportunities for differentiation'.
Andrew Chan, Managing Director, Head of Valuation & Advisory Services, Greater China, said,' Looking ahead to 2025 and beyond, growth opportunities lie in AI-driven drug discovery, personalised medicine, advanced therapeutics (CGT, RNA), and green-certified facilities. Government policies continue to support innovation through fast-track approvals, rare disease funding, and subsidies aligned with dual-carbon and ESG goals'.
Shaun Brodie, Head of Research Content, Greater China, 'Life sciences real estate is shifting from generic parks to specialised, digitally enabled campuses with high compliance and flexibility. Investment strategies increasingly emphasise long-term partnerships, collaborative operating models, and digital infrastructure. Both landlords and occupiers express cautious optimism, with strategic differentiation and regional targeting seen as keys to unlocking future value'.
Please click here to download the full report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
4 hours ago
- The Star
China, Zimbabwe ink cooperation deal, food assistance package
HARARE, Aug. 6 (Xinhua) -- China and Zimbabwe on Wednesday signed an agreement on economic and technical cooperation and exchange of letters for a new batch of food assistance to boost Zimbabwe's socio-economic development and food security. Zimbabwean President Emmerson Mnangagwa presided over the signing ceremony at the State House, where Zimbabwean Minister of Finance and Economic Development Mthuli Ncube thanked China for its continued support to various economic sectors in Zimbabwe. He said that the previous economic and technical cooperation agreement signed between the two countries in 2020 has supported, among other projects, the drilling of boreholes across the country and the implementation of the Juncao technology assistance project that helps Zimbabwean farmers to cultivate hybrid grass rich in protein. "The government of Zimbabwe sincerely appreciates and acknowledges the emergency food assistance continuously received from China," Ncube said. "Indeed, China has demonstrated that they are our all-weather friend through the invaluable support they have consistently rendered to the people of Zimbabwe." For his part, Chinese Ambassador to Zimbabwe Zhou Ding said the agreements were a testimony of the resilient ties between the two countries and the affirmation of China's unwavering solidarity with Zimbabwe. He said the economic and technical cooperation agreement, as well as the food assistance, were part of the 17 cooperation agreements signed between China and Zimbabwe during Mnangagwa's state visit to China last year. "Time and again, we have proven that we are bound by a shared future, standing side by side through every trial. We cherish this profound and enduring friendship, and will continue to stand together in the face of all challenges," Zhou said. The Chinese ambassador noted that the comprehensive strategic partnership of cooperation between the two countries has flourished across all Zimbabwean sectors, bringing tangible benefits to both nations and setting a shining example for South-South cooperation. China remains firmly committed to supporting Zimbabwe in realizing its Vision 2030 and advancing its socio-economic transformation, Zhou added.


The Star
7 hours ago
- The Star
South Korea to offer visa-free entry to Chinese tourists from late September
A large crowd of tourists walks through Bukchon Hanok Village in Seoul, South Korea, October 25, 2024. - Photo: Reuters file SEOUL: South Korea will offer visa-free entry to tourist groups from China, for a temporary period from September 29 through June 2026, to boost foreign tourism ahead of an Asia-Pacific summit, the government said on Wednesday (Aug 6). The visa-free offer was first announced in March after China's decision last November to offer a visa exemption to South Koreans and foreign visitors from other countries. The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here. It also comes amid expectations that ties between the two countries will improve under the new South Korean administration of liberal President Lee Jae Myung. The decision to introduce the measure ahead of a Chinese holiday period in early October will help boost the domestic economy amid a recovery in foreign visits, the tourism ministry said, after a meeting to discuss measures to revitalise tourism ahead of the Asia-Pacific summit. South Korea will host a summit of leaders from 21 economies for the Asia-Pacific Economic Cooperation (APEC) forum from October 31 to November 1 in the southeastern city of Gyeongju, a gathering where Chinese leader Xi Jinping and U.S. President Donald Trump might hold separate talks. Shares of South Korean department stores, casinos, hotels and beauty product makers rallied on hopes of a boost from Chinese demand. Hyundai Department Store ( opens new tab shares jumped 7.1%, Hotel Shilla ( opens new tab rose 4.8%, casino operator Paradise ( opens new tab climbed 2.9% and Hankook Cosmetics ( opens new tab surged 9.9%. - Reuters


The Star
8 hours ago
- The Star
EU may have just deepened its reliance on the US, former Chinese envoy says
The latest trade deal between Brussels and Washington may deepen the European Union's economic and security dependence on the US and increase the risks to the bloc's pursuit of strategic autonomy, according to a senior Chinese diplomat. Shi Mingde, who served as China's ambassador to Germany from 2012 to 2019, gave his assessment of Sunday's transatlantic agreement to academics and reporters at an event in Beijing on Tuesday to mark 50 years of China-EU relations. The deal came hard on the heels of last Thursday's one-day EU-China summit in the Chinese capital, which also marked the 50th anniversary of the establishment of diplomatic ties between China and the 27-member bloc. While Beijing has supported Europe's push for strategic autonomy, it has firmly rejected its de-risking policy – to reduce the EU's reliance on China – as a veiled attempt to contain Chinese growth, particularly in technology and the economy. 'The Europeans have proposed to reduce reliance to mitigate risk, but this reasoning is flawed,' Shi said. 'They claim that greater reliance leads to greater risk, yet their dependence on the United States remains even stronger – both in terms of security and economics – and the recent deal ... further reinforces the EU's dependence on the US in terms of security and the economy. 'So, will this agreement ultimately lead to greater strategic autonomy for Europe? Not yet.' Touted by US President Donald Trump as 'the biggest deal ever made', the agreement puts a 15 per cent tariff on most European imports to the United States, while the average rate on goods in the other direction will drop below one per cent, according to the White House. The EU has also agreed to buy US$750 billion in American energy and make US$600 billion in new investment in the United States – all by 2028. There have been concerns that a transatlantic agreement may increase Trump's leverage in the continuing trade talks with Beijing while allowing the US and the EU to refocus on their alignment in the competition with China. On Monday, EU trade chief Maros Sefcovic said that as part of the deal, Washington and Brussels would develop a metals alliance to mitigate the impact of subsidised Chinese products – notably 'steel, aluminium, copper and the derivatives' – on global markets. Without going into the agreement's details, Shi said that while Beijing's policy with the bloc had been 'consistent' and 'cooperative', it was the EU's own job to shape its future with major powers like the US, China and Russia. How Sino-EU relations develop would depend on how the bloc definef China, 'but the premise is how the EU defines itself in a turbulent world', he said. '[Would Brussels really] want a full-scale confrontation with Russia, comprehensive suppression by the US ... and an increasingly fractious relationship with China?' Despite the frictions in the relationship, China has positioned itself as a partner to Europe and has been encouraging the European Union to do more to assert its strategic autonomy. At last week's summit, expected to set the tone for China-EU relations, President Xi Jinping urged his visitors – European Commission chief Ursula von der Leyen and the president of the European Council Antonio Costa – to make 'the right strategic choice'. Speaking before Shi at the same event, Di Dongsheng, professor and associate dean of the Renmin University of China's school of international studies, observed that the EU's policy on China had been largely influenced by Washington rather than Beijing. The results of a 2023 study by his team at Renmin University suggested there was a risk that the EU might use China as leverage if Brussels was pressed hard by the US, he said. The researchers analysed more than 200 million recorded events – including diplomatic engagement and conflicts – related to relations between China, the US and Washington's allies since 2009, when former president Barack Obama took office. 'Our research shows Europe's China policy isn't shaped by Beijing's actions at all – whether we're positive or negative makes no difference in the EU's attitude on China,' Di said. 'The real decider is America's stance towards China and, to a lesser extent, the United States' attitude towards the EU. 'In this sense, when the Europeans talk about cutting dependence on China, in the economy and supply chains, I think they should also be pursuing real political and strategic autonomy.' - South China Morning Post